title: Humane anesthesia and pain management in amphibian limb surgery of Rana pipiens.
abstract: Adult Rana pipiens frogs are used as a model to investigate mechanisms of vertebrate organ regeneration, anti-tumor ribonucleases, zoological impacts of various pollutants, oncogenesis, neuroplasticity, and neurogenesis. In regenerative biology, the adult Rana pipiens frog is an important alternative to other frog models, such as Xenopus laevis, because it offers the opportunity to study and attempt to augment limb regeneration in an animal that spends significant time out of water and bears weight on its limbs. To elucidate regenerative processes, it is necessary to amputate the limb to study the processes associated with wound healing, blastema formation, and morphogenesis. Being able to revive the animal successfully with little or no side effects is paramount to these studies. Anesthesia and the effect it has on the frogs can vary based on the methods and post-operative care exercised during surgery. However, useful information is not readily available regarding current anesthesia methods or effective and humane analgesia use in amphibians. Amphibian patients are very sensitive to drug dosages, changes in temperature, humidity and water quality; here, special attention is given to these factors. This protocol establishes a humane anesthesia technique while maintaining physiological homeostasis during procedures in amphibians as well as a post-operative care plan addressing the clinical benefits of using analgesics in pain management. Suggestions for infection prevention are covered with a sample treatment plan to ensure that all of the animals have a positive outcome and all of the surgeries have reproducible results.
authors: Center for Regenerative and Developmental Biology and Department of Biology, Tufts University, Medford, Massachusetts 02155, USA.
authors: Punita
authors: P
authors: Koustubhan
authors: David L
authors: DL
authors: Kaplan
authors: Michael
authors: M
authors: Levin
mesh_terms: D000758:Anesthesia; D000818:Animals; D005121:Extremities / Q000601:surgery*; D023421:Models, Animal; D059408:Pain Management; D011894:Rana pipiens
references: Environ Toxicol Chem. 2009 Jul;28(7):1469-74
references: 19236124
references: Altern Lab Anim. 2007 Oct;35(5):463-70
references: 18001168
references: J Comp Neurol. 1976 Nov 1;170(1):33-51
references: 1086313
references: Int J Oncol. 2007 Sep;31(3):663-9
references: 17671695
references: Am J Pathol. 1976 Oct;85(1):183-94
references: 1086063
references: BioDrugs. 2008;22(1):53-8
references: 18215091
references: J Natl Cancer Inst. 1976 Jul;57(1):79-84
references: 1087345
references: Contemp Top Lab Anim Sci. 2001 Jul;40(4):23-7
references: 11451391
references: ILAR J. 2007;48(3):255-9
references: 17592187
references: Environ Toxicol Pharmacol. 2001 Jul;10(3):119-21
references: 21782566
references: Cell Cycle. 2007 Dec 15;6(24):3097-102
references: 18073526
references: J Exp Zool. 1977 Jun;200(3):403-16
references: 301554
references: J Am Assoc Lab Anim Sci. 2012 Mar;51(2):253-6
references: 22776127
references: J Embryol Exp Morphol. 1981 Jun;63:243-65
references: 6975797
references: Virology. 2001 Sep 30;288(2):351-7
references: 11601906
references: Dev Comp Immunol. 2005;29(1):83-90
references: 15325526
references: J Pharmacol Toxicol Methods. 1994 Sep;32(1):59
references: 7833509
references: Curr Pharm Biotechnol. 2008 Jun;9(3):215-25
references: 18673287
references: J Comp Neurol. 2009 May 1;514(1):30-48
references: 19260054
references: Anat Rec. 1967 May;158(1):89-97
references: 6033441
references: Pharmacol Rep. 2005 Jul-Aug;57(4):467-74
references: 16129913
references: Eur J Biochem. 2000 Feb;267(3):894-900
references: 10651828
references: J Comp Neurol. 1976 Nov 1;170(1):17-31
references: 1086312